THOMAS RAWSON: Open Payments
NPI 1417251190 · LEHIGH ACRES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,241 in 49 payments from 12 companies in 2025. Trend: 2023 $1,122 · 2024 $1,793 · 2025 $1,241
Food & beverage: $1,241
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $222 |
| Axsome Therapeutics, Inc. | 7 | $220 |
| Vanda Pharmaceuticals Inc. | 7 | $198 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $114 |
| Neurocrine BioSciences, Inc. | 4 | $107 |
| E.R. Squibb & Sons, L.L.C. | 5 | $105 |
| ABBVIE INC. | 4 | $85 |
| Janssen Pharmaceuticals, Inc | 3 | $76 |
| Lundbeck LLC | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
Products named: TRINTELLIX, Auvelity, FANAPT, CAPLYTA, INGREZZA, COBENFY, VRAYLAR, SPRAVATO.
Industry payments across FL — which companies pay providers there.
